BDBM447445 (2S,4R)-4-(4-[1,2,3]Triazol-2-yl-2-trifluoromethyl-benzenesulfonyl)-1-(1-trifluoromethyl-cyclopropanecarbonyl)-pyrrolidine-2-carboxylic acid (1-cyano-cyclopropyl)-amide::US10689339, Example 53

SMILES FC(F)(F)c1cc(ccc1S(=O)(=O)[C@@H]1C[C@H](N(C1)C(=O)C1(CC1)C(F)(F)F)C(=O)NC1(CC1)C#N)-n1nccn1

InChI Key InChIKey=HDHFSTXKLFGACF-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 447445   

TargetCathepsin S(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM447445(US10689339, Example 53 | (2S,4R)-4-(4-[1,2,3]Triaz...)
Affinity DataIC50: 0.506nMAssay Description:Enzyme activity is measured by observing the increase in fluorescence intensity caused by cleavage of a peptide substrate containing a fluorophore wh...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2021
Entry Details
Go to US Patent